medigraphic.com
Revista Médica Sinergia

2019, Number 06

<< Back Next >>

Revista Médica Sinergia 2019; 4 (06)

Cutaneous manifestations in lupus erythematosus, systemic sclerosis and dermatomyositis

Zumbado VR, Hines CKD, Castro CV

Language: Spanish
References: 18
Page: 53-59
PDF size: 403.71 Kb.


ABSTRACT

Many rheumatologic diseases are characterized by having heterogeneous clinical manifestations; these can present solely as cutaneous lesions or affect multiple internal organs. Most of these patients will have dermatologic manifestations, which in many cases will be the first sign of the underlying disease. Identifying the different skin lesions in these diseases will help diagnose and control them early and adequately. This review will focus on three of the main rheumatologic diseases: lupus erythematosus, systemic sclerosis and dermatomyositis.


REFERENCES

  1. Naesström M, Kakol M, Kamkar V, Baranska-Rybak W, Sokolowska-Wojdylo M, Stawczyk M, Nowicki R. A rarity that can lead to a casualty - A retrospective study of 12 cases of Dermatomyositis. British Journal of Medical Practitioners. 2015; 8(3): a822. Disponible en:http://www.bjmp.org/content/rarity-can-leadcasualty- retrospective-study-12-cases-dermatomyositis

  2. Kumánovics G, Péntek M, Bae S, Opris D, Khanna D, Furst DE, Czirják L. Assessment of skin involvement in systemic sclerosis. Rheumatology. 2017 09 01;56(suppl_5):v53- v66.https://doi.org/10.1093/rheumatology/kex202

  3. Fitzpatrick T, Goldsmith L, Wolff K. Dermatología en Medicina General. 8va ed. Nueva York: McGraw-Hill; 2012. p. 1909-1956

  4. Mainetti C, Beretta-Piccoli BT, Selmi C. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clinical Reviews in Allergy & Immunology. 2017; 53(3): 337–356.https://doi.org/10.1007/s12016- 017-8652-1

  5. Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. Journal of Autoimmunity. 2014 02; 48-49: 14-19. https://doi.org/10.1016/j.jaut.2014.01.021

  6. Fadhel SD, Silva ACD. Lupus Erythematosus, Dermatomyositis and Systemic Sclerosis: Assessment and Differentials from A Dermatologic Point of View. Lupus Erythematosus, Dermatomyositis and Systemic Sclerosis: Assessment and Differentials from A Dermatologic Point of View. Enliven: clinical dermatology [Internet]. 2018 [citado 2019 Mar 18]; 4(1): 002. Disponible en:https://www.researchgate.net/publication/326804551_Lupus_Erythematosus_Dermatomyositis_and_S ystemic_Sclerosis_Assessment_and_Differentials_from_A_Dermatologic_Point_of_View

  7. Kuhn A, Bonsmann G, Anders H, Herzer P, Tenbrock K, Schneider M. The Diagnosis and Treatment of Systemic Lupus Erythematosus. Deutsches Aerzteblatt Online. 2015 06 19; 112(25): 423- 432. https://doi.org/10.3238/arztebl.2015.0423

  8. Kuhn A, Landmann A, Bonsmann G. The skin in autoimmune diseases - Unmet needs. Autoimmunity Reviews. 2016 Oct; 15(10): 948-954. https://doi.org/10.1016/j.autrev.2016.07.013

  9. Stannard JN, Kahlenberg JM. Cutaneous lupus erythematosus. Current Opinion in Rheumatology. 2016 09; 28(5) :453-459. https://doi.org/10.1097/bor.0000000000000308

  10. Okon L, Werth V. Cutaneous lupus erythematosus: Diagnosis and treatment. Best Practice & Research Clinical Rheumatology. 2013 06; 27(3): 391-404.https://doi.org/10.1016/j.berh.2013.07.008

  11. Tiao J, Feng R, Carr K, Okawa J, Werth VP. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE). Journal of the American Academy of Dermatology. 2016 05; 74(5): 862- 869. https://doi.org/10.1016/j.jaad.2015.12.029

  12. Inęs L, Silva C, Galindo M, López-Longo FJ, Terroso G, Romăo VC, Rúa-Figueroa I, et al. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. Arthritis Care & Research. 2015 07 26; 67(8) :1180- 1185. https://doi.org/10.1002/acr.22539

  13. Yeoh S, Dias SS, Isenberg DA. Advances in systemic lupus erythematosus. Medicine. 2018 02; 46(2): 84- 92. https://doi.org/10.1016/j.mpmed.2017.11.010

  14. Muro Y, Sugiura K, Akiyama M. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features - a Comprehensive Review. Clinical Reviews in Allergy & Immunology. 2015 06 23; 51(3): 293-302. https://doi.org/10.1007/s12016-015-8496-5

  15. Denton CP, Khanna D. Systemic sclerosis. The Lancet. 2017 Oct; 390(10103): 1685- 1699.https://doi.org/10.1016/s0140-6736(17)30933-9

  16. Pearson DR, Werth VP, Pappas-Taffer L. Systemic sclerosis: Current concepts of skin and systemic manifestations. Clinics in Dermatology. 2018 07; 36(4): 459- 474.https://doi.org/10.1016/j.clindermatol.2018.04.004

  17. Guiducci S, Bellando-Randone S, Matucci-Cerinic M. A New Way of Thinking about Systemic Sclerosis: The Opportunity for a Very Early Diagnosis. Israel Medical Association Journal [Internet]. 2016 [citado 2019 Mar 22]; 18(3-4), 141-143. Disponible en:https://www.ima.org.il/FilesUpload/IMAJ/0/193/96902.pdf

  18. Bellando-Randone S, Matucci-Cerinic M. Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions. Current Rheumatology Reports. 2017 09 18; 19: 65. https://doi.org/10.1007/s11926-017-0684-2




2020     |     www.medigraphic.com